Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies
L Degenhardt, B Clark, G Macpherson… - The Lancet …, 2023 - thelancet.com
Background Opioid dependence is associated with substantial health and social burdens,
and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for …
and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for …
Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …
[HTML][HTML] Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence
Background Opioid agonist treatment (OAT) is an effective intervention for opioid
dependence. Extended-release buprenorphine injections (BUP-XR) may have additional …
dependence. Extended-release buprenorphine injections (BUP-XR) may have additional …
[HTML][HTML] “You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
Background Opioid agonist treatment (OAT) improves multiple health and social outcomes,
yet requirements to attend for supervised dosing can be burdensome and stigmatising. The …
yet requirements to attend for supervised dosing can be burdensome and stigmatising. The …
New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review
N Power, L Archambault… - Journal of Drug …, 2024 - journals.sagepub.com
Changes to the landscape of opioid use have occurred throughout the past two decades.
Opioid agonist treatment (OAT) plays an important role in reducing opioid-related harms …
Opioid agonist treatment (OAT) plays an important role in reducing opioid-related harms …
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A …
Background A precipitous decline in health status among people recently released from
prison is common. In Victoria, Australia, opioid agonist treatment (OAT) in the community …
prison is common. In Victoria, Australia, opioid agonist treatment (OAT) in the community …
[HTML][HTML] Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: a …
Background Retention in opioid agonist treatment (OAT) following release from prison is
associated with improved outcomes, however factors associated with post-release OAT …
associated with improved outcomes, however factors associated with post-release OAT …
[HTML][HTML] 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow …
M Farrell, J Shahbazi, M Chambers, M Byrne… - International Journal of …, 2024 - Elsevier
Background The most recent formulation of buprenorphine treatment is extended-release
depot injections (BUP-XR) that are administered subcutaneously by health care …
depot injections (BUP-XR) that are administered subcutaneously by health care …
Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia
S Settumba, J Shahbazi, M Byrne… - Drug and Alcohol …, 2024 - Wiley Online Library
Introduction The costs of providing medication‐assisted treatment for opioid dependence
can determine its scale of provision. To provide estimates of the costs of extended‐release …
can determine its scale of provision. To provide estimates of the costs of extended‐release …
[PDF][PDF] Non‐fatal opioid overdose after release from prison among men who injected drugs prior to their imprisonment: a prospective data linkage study
In the first two weeks after their release from prison, people are at greater risk than usual of
fatal opioid overdose. 1 They are also at greater risk of non-fatal opioid overdose, 2 which is …
fatal opioid overdose. 1 They are also at greater risk of non-fatal opioid overdose, 2 which is …